cefonicid has been researched along with cefotaxime in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Marone, P; Monzillo, V; Navarra, A; Traverso, A | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Dudley, MN; Nightingale, CH; Quintiliani, R; Shyu, WC | 1 |
| Figini, G; Germiniani, R; Mastropasqua, E; Mauri, J; Rosina, M | 1 |
| Brogard, JM; Comte, F | 1 |
| Bayer, AS; Kim, KS; Morrison, JO | 1 |
| Gruninger, RP; Khan, MY; Siddiqui, Y | 1 |
| Eyal, A; Greif, F; Lelcuk, S; Shalit, I | 1 |
1 review(s) available for cefonicid and cefotaxime
| Article | Year |
|---|---|
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
8 other study(ies) available for cefonicid and cefotaxime
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli.
Topics: Bacteroides fragilis; Cefonicid; Cefotaxime; Cefotetan; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Microbial Sensitivity Tests; Piperacillin | 1990 |
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
Topics: Anti-Bacterial Agents; Aztreonam; Cefamandole; Cefonicid; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cefuroxime; Enterococcus faecalis; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Thienamycins | 1987 |
Effect of protein binding on drug penetration into blister fluid.
Topics: Adult; Blister; Blood Proteins; Cefamandole; Cefonicid; Cefotaxime; Ceftizoxime; Extracellular Space; Female; Humans; Male; Protein Binding; Tissue Distribution | 1988 |
[In vitro sensitivity of hospital-isolated pathogenic bacterial strains to 4 different cephalosporins: cephaloridine, cefotaxime, cefoxitin, cefonicid].
Topics: Bacteria; Cefamandole; Cefonicid; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests | 1986 |
Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci.
Topics: Cefamandole; Cefonicid; Cefotaxime; Ceftizoxime; Cephalosporins; Dose-Response Relationship, Drug; Penicillin G; Penicillin Resistance; Streptococcus agalactiae | 1982 |
Comparative in-vitro activity of selected new beta-lactam antimicrobials against Neisseria gonorrhoeae.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefonicid; Cefotaxime; Cefotiam; Ceftriaxone; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1982 |
Acute bacterial peritonitis: permeability of cephalosporins in the peritoneal cavity.
Topics: Acute Disease; Animals; Bacterial Infections; Cefazolin; Cefonicid; Cefotaxime; Cephalosporins; Drug Evaluation, Preclinical; Drug Monitoring; Peritoneal Cavity; Peritonitis; Random Allocation; Rats; Rats, Wistar; Tissue Distribution | 1996 |